Site Maintenance will take place from 4:00 PM on 2024-04-29 to 9:00 AM on 2024-05-01.
Please do not make any content change during this time, otherwise all the changes will be lost.

Select Publications

Journal articles

Dore GJ; Brew BJ, 2000, 'Response to Eberly et al., Kaposi¿s sarcoma and central nervous system disease: a real association or an artifact of the control group? (letter)', AIDS, 14, pp. 2631 - 2632

Dore GJ, 2000, 'Sexual transmission of hepatitis C: what is the evidence?', Australian Hepatitis Chronicle, pp. 2 - 5

Kaldor JM; Dore GJ; Correll PK, 2000, 'Towards control of hepatitis C in the Asia-Pacific region ¿ Public health challenges in hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 15, pp. E83 - E90

Lurie P; Wolfe SM; McNeill PM; Dore GJ, 1999, 'Should research ethics change at the border? (multiple letters) [6]', Medical Journal of Australia, 171, pp. 167 - 168, http://dx.doi.org/10.5694/j.1326-5377.1999.tb123586.x

Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ, 1999, 'Changes to AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, 13, pp. 1249 - 1253

Dore GJ; Cooper DA; Barrett C; Goh L; Thakrar B; Atkins M, 1999, 'Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR)', Journal of Infectious Diseases, 180, pp. 607 - 613

Dore GJ; Law MG; Kaldor JM, 1999, 'Prevalence of hepatitis C virus infection in the United States', New England Journal of Medicine, pp. 2093 - 2094 (lett

Mcneil PM; Dore GJ, 1999, 'Should research ethics change at the border?', Medical Journal of Australia, 171, pp. 168 - (letter)

Dore GJ; Pritchard-Jones J; Fisher D; Law MG, 1999, 'Who's at risk: risk factors for HCV infection in Australia', Australian Family Physician, pp. 8 - 13

Wettstein AR; Dore G; Murphy C; Edwards PD, 1998, 'HIV related cholangiopathy (HIVRC): Is endoscopic biliary sphincterotomy (EBS) an effective therapy?', Gastrointestinal Endoscopy, 47

McNeill PM, 1998, 'Should research ethics change at the border?', Medical Journal of Australia, 169, pp. 509 - 510, http://dx.doi.org/10.5694/j.1326-5377.1998.tb123394.x

Collignon P; Dore GJ; Li Y; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality rates (multiple letters) [3]', Medical Journal of Australia, 169, http://dx.doi.org/10.5694/j.1326-5377.1998.tb126845.x

Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C - Summary vertical transmission rates may be misleading - Reply', BRITISH MEDICAL JOURNAL, 316, pp. 554 - 554, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072097400048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas S; Hall A; Newell ML; Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C (multiple letters) [5]', British Medical Journal, 316, pp. 553 - 554

Hira SK; Dore GJ; Sirisanthana T, 1998, 'Clinical spectrum of HIV/AIDS in the Asia-Pacific region.', AIDS (London, England), 12 Suppl B

Dore GJ, 1998, 'Chronic hepatitis C infection: a disease ideally suited to management in the primary care setting', Australian Family Physician, pp. 791 - 793

McDonald AM; French R; Dore GJ; Hamernik E; Kippax SC; Ashton LJ, 1998, 'Epidemiological and social research findings reported at the 12th World AIDS Conference, Geneva 1998', Australian HIV Surveillance Report, 14, pp. 1 - 9

Crofts JN; Dore GJ; Kaldor JM; Law MG; Wodak AD; Et A, 1998, 'Estimates and projections of the hepatitis C virus epidemic in Australia', ION Meeting Proceedings

Dore GJ; Brown TA; Tarantola D; Kaldor JM, 1998, 'HIV and AIDS in the Asia-Pacific region: an epidemiological overview', AIDS, 12, pp. S1 - S10

Van Beek IA; Dwyer RG; Dore GJ; Luo K; Kaldor JM, 1998, 'Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study', British Medical Journal: International, pp. 433 - 437

Dore GJ; Grulich AE; Law MG; Brew BJ; Kaldor JM, 1998, 'Kaposi¿s sarcoma and protection from AIDS dementia complex', AIDS, 12, pp. 2354 - 2355

Dore GJ; Kaldor JM; Mccaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C', British Medical Journal: International, pp. 553 - 554

Dore GJ, 1998, 'Report from the 4th International Conference on AIDS in Asia and the Pacific', Noah's Arc

Dore GJ; Kaldor JM, 1998, 'Sexually transmissible diseases surveillance in Australia: towards a coordinated national system', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, pp. 49 - 52

Dore GJ; Li YW; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality in Australia, 1979-1994', Medical Journal of Australia, 168, pp. 601 - 604

Dore GJ; Li YW; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality rates', Medical Journal of Australia, 169, pp. 444 - 445, http://dx.doi.org/10.5694/j.1326-5377.1998.tb126846.x

Aguado JM; Pulido F; Dore GJ; Law MG; Kaldor JM; Gordin F; Matts J, 1997, 'Isoniazid prophylaxis for high-risk patients with anergy and HIV infection [4] (multiple letters)', New England Journal of Medicine, 337, pp. 1696 - 1697, http://dx.doi.org/10.1056/NEJM199712043372316

Dore GJ; Law MG; Kaldor JM, 1997, 'Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.', The New England journal of medicine, 337, pp. 1697

Dore GJ; Law MG; Brew BJ, 1997, 'Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection', Journal of Neuro-AIDS, 1, pp. 59 - 69, http://dx.doi.org/10.1300/J128v01n04_06

Gray JA; Dore GJ; Li Y; Supawitkul S; Effler P; Kaldor JM, 1997, '"HIV-1 Infection among Female Commercial Sex Workers in Rural Thailand."', Studies in Family Planning, 28, pp. 168 - 168, http://dx.doi.org/10.2307/2138125

Dore GJ; Law MG; Kaldor JM, 1997, 'A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis', New England Journal of Medicine, pp. 315 - 320

Gray JA; Dore GJ; Li Y; Supawitkul S; Effler P; Kaldor JM, 1997, 'HIV-1 infection among female commercial sex workers in rural Thailand', AIDS, 11, pp. 89 - 94

Dore GJ; Kaldor JM; Mccaughan GW, 1997, 'Systematic review of role of polymerase chain reaction in defining infectiousness among people with hepatitis C virus', British Medical Journal: Clinical Research, pp. 333 - 337

Dore GJ; Hoy JF; Mallal SS; Li YW; Mijch AM; French MA; Cooper DA; Kaldor JM, 1997, 'Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS Cohort', Journal of acquired immune deficiency syndrome and human retrovirology, 16, pp. 39 - 43

Dore GJ; Kaldor JM; Ungchusak K; Mertens TE, 1996, 'Epidemiology of HIV and AIDS in the Asia-Pacific region', Medical Journal of Australia, 165, pp. 494 - 498, http://dx.doi.org/10.5694/j.1326-5377.1996.tb138615.x

Dore GJ; Kaldor JM; Ungchusak K; Mertens TE, 1996, 'Managing HIV .9. HIV in Asia and the Pacific - Epidemiology of HIV and AIDS in the Asia-Pacific region', MEDICAL JOURNAL OF AUSTRALIA, 165, pp. 494 - 498, http://dx.doi.org/10.5694/j.1326-5377.1996.tb138615.x

Dore GJ; Li YW; Mallal SA; Hoy JF; Mijch AM; French MA; Cooper DA; Kaldor JM; Grulich AE, 1996, 'Declining incidence and later occurrence of Kaposi`s sarcoma among people with AIDS in Australia: the Australian AIDS cohort', AIDS, 10, pp. 1401 - 1406

Couldwell D; Dore GJ; Harkness JL; Marriott D; Cooper DA; Edwards RJ; Li YW; Kaldor JM, 1996, 'Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room', AIDS, 10, pp. 521 - 525

Law MG; Dore GJ; McDonald AM; Kaldor JM, 1996, 'The use of back-projection to estimate HIV prevalence in pregnant women', Paediatric AIDS and HIV Infection, pp. 331 - 336

Dore GJ; Marriot DJ; Duflou J, 1995, 'Clinico-pathological study of cytomegalovirus infection (CMV) is AIDS autopsies: under-recognition of CMV pneumonitis and CMV adrenalitis', Australian and New Zealand Journal of Medicine, pp. 503 - 506

Dore GJ; Marriott D; Hing MC; Harkness JL; Field AS, 1995, 'Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with Human Immunodeficiency virus: Response to therapy with Albendazole', Clinical Infectious Diseases, pp. 70 - 76


Back to profile page